From the Proteome to Therapeutics: A Multi-Database Approach to Drug Discovery in Periodontitis-An Exploratory Pilot
Taisir Bozo1, Annette Murr2, Birte Holtfreter1
1Department of Restorative Dentistry, Periodontology and Endodontology, University Medicine Greifswald, Greifswald, Germany.
Journal of Clinical Periodontology
|May 5, 2026
Summary
This study introduces a workflow to find approved drugs for periodontitis treatment by analyzing saliva proteins and drug targets. Eight drugs show potential for repurposing, with some already demonstrating efficacy in preclinical models.
Area of Science:
- Biomolecular Sciences
- Pharmacology
- Periodontology
Background:
- Periodontitis poses a significant global health challenge.
- Current treatments for periodontitis have limitations.
- Novel therapeutic strategies are needed for effective periodontitis management.
Purpose of the Study:
- To develop and validate a workflow for identifying approved drugs that can be repurposed for periodontitis therapy.
- To leverage salivary proteomics and drug-target databases for drug discovery.
- To identify potential drug candidates for periodontal treatment.
Main Methods:
- Salivary proteomic analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in two independent study settings.
- Statistical analysis employing stringent and lenient criteria to identify potential protein targets.
- Drug-target database screening to identify approved drugs associated with identified protein targets.
Main Results:
- A workflow successfully identified potential therapeutic targets and drug candidates for periodontitis.
- One (nine) protein targets were identified as known drug targets, with one (seven) being potential targets in periodontitis.
- Eight approved drugs were identified as having potential for repurposing in periodontal treatment, with several showing preclinical efficacy.
Conclusions:
- The developed workflow is effective in identifying approved drugs for periodontitis repurposing.
- This approach offers a promising strategy for discovering novel periodontal therapies.
- Further investigation into the identified drugs may lead to new treatment options for periodontitis.

